Gan & Lee Pharmaceuticals. (SHA:603087)

SHA:603087 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	42,569	26,332	31,066	18,429	39,499	74,247
Market Cap Growth	87.96%	-15.24%	68.57%	-53.34%	-46.80%	-
Enterprise Value	40,336	21,268	26,918	13,463	34,935	70,382
Last Close Price	71.52	43.35	50.98	31.55	67.67	126.80
PE Ratio	46.20	42.84	91.35	-	27.19	60.33
Forward PE	36.68	11.40	11.40	11.40	25.81	50.01
PS Ratio	11.21	8.65	11.91	10.76	10.94	22.09
PB Ratio	3.88	2.38	2.89	1.92	3.89	8.31
P/TBV Ratio	3.98	2.44	2.97	1.98	4.00	8.54
P/FCF Ratio	360.26	272.84	-	-	102.30	112.63
P/OCF Ratio	59.15	49.01	283.83	62.12	36.64	59.81
EV/Sales Ratio	10.62	6.98	10.32	7.86	9.67	20.94
EV/EBITDA Ratio	41.70	38.98	67.16	-	22.24	44.70
EV/EBIT Ratio	57.73	72.20	149.52	-	25.13	49.75
EV/FCF Ratio	341.36	220.38	-	-	90.48	106.77
Debt / Equity Ratio	0	0	0.00	0.00	0.00	-
Debt / EBITDA Ratio	0.00	0.01	0.02	-	0.01	-
Debt / FCF Ratio	0.03	0.05	-	-	0.05	-
Asset Turnover	0.32	0.26	0.23	0.16	0.36	0.43
Inventory Turnover	0.89	0.81	0.96	0.68	0.70	0.64
Quick Ratio	3.74	3.31	6.77	6.05	12.65	13.14
Current Ratio	5.40	4.73	7.99	6.97	14.15	14.54
Return on Equity (ROE)	8.38%	5.64%	3.35%	-4.45%	15.21%	17.08%
Return on Assets (ROA)	3.67%	1.55%	1.01%	-3.94%	8.54%	11.39%
Return on Capital (ROIC)	3.98%	1.69%	1.11%	-4.27%	9.09%	12.27%
Return on Capital Employed (ROCE)	6.30%	2.60%	1.60%	-	13.40%	15.60%
Earnings Yield	2.16%	2.33%	1.09%	-2.38%	3.68%	1.66%
FCF Yield	0.28%	0.37%	-1.43%	-3.73%	0.98%	0.89%
Dividend Yield	2.18%	3.46%	0.39%	-	0.44%	0.32%
Payout Ratio	99.70%	68.42%	-	-	15.46%	16.30%
Buyback Yield / Dilution	-2.34%	-4.28%	-0.58%	-0.46%	-5.28%	-5.43%
Total Shareholder Return	-0.16%	-0.82%	-0.19%	-0.46%	-4.84%	-5.12%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.